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Objective: To explore the protection and molecular mechanism of histone deacetylase
inhibitors (HDACIs) on the spleen of rats with hemorrhagic shock.
Methods: A total of 60 SPF male SD rats were selected for the modeling of severe
hemorrhagic shock using the method of arterial and venous cannulation with the time-
divided bleeding. The measurement of mean arterial blood pressure and blood lactic
acid was used to verify the modeling. The modeled rats were randomly divided into shock
group, shock + suberoylanilide hydroxamic acid (SAHA) group, shock + autogenous
transfusion group and shock + SAHA + autogenous transfusion group. Three hours after
the treatment, the spleen of rats was collected and TUNEL method was employed to
detect the apoptosis of spleen cells in each group. The statistical analysis was performed.
Afterwards, real-time PCR and western blot were employed to detect the expression of
BCL-2, BAX and caspass3 in the spleen of rats in each group.
Results: A total of 53 rats had successful modeling of severe hemorrhagic shock, with
success rate of 88%. Cell apoptosis in the severe hemorrhagic model group was the most
serious. After the intervention of HDACIs and the autogenous transfusion, the tissue
injury was a bit recovered. Cell apoptosis was least in the shock + SAHA + autogenous
transfusion group (P < 0.05). After the intervention of HDACIs and the autogenous
transfusion, the relative expression of BCL-2 was signiﬁcantly increased (P < 0.05), with
highest relative expression of BCL-2 in shock + SAHA + autogenous transfusion group
(P < 0.05). After the intervention of HDACIs and the autogenous transfusion, the relative
expression of BAX was signiﬁcantly decreased (P < 0.05), with lowest relative
expression of BAX in the intervention group of single HDACIs. The change in the
expression of caspass3 was similar to BAX, namely the relative expression of caspass3
was signiﬁcantly decreased after the intervention of HDACIs and the autogenous trans-
fusion (P < 0.05).
Conclusions: HDACIs and autogenous transfusion can all protect the spleen injury
because of the severe hemorrhagic shock. Its molecular mechanism may be related to the
regulation on the expression of BCL-2/BAX and caspass3, which may affect the
apoptosis process of cells.1. Introduction
The histone deacetylase inhibitor (HDACI) is a family of
compounds, including butyrate, phenyl butyrate, hydroxamicacid TSA, valproic acid (VPA) and suberoylanilide hydroxamic
acid (SAHA). With the function of intervention and histone
deacetylase, HDACIs could increase the degree of acetylation
in the histone of cells to increase the expression of genes such
as p21, inhibit the proliferation of tumor cells and induce the
cellular differentiation and apoptosis [1,2]. Thus HDACIs were
regarded as a type of new cancer therapeutic drug. Hidehiko K
et al. reported that several HDACIs had the Phases I, II and III
clinical trials [3]. These clinical trials mainly included the
hematological malignancies such as the chronic myeloid
leukemia. Meanwhile, the previous studies also reported thatcle under the CC BY-NC-ND license (http://
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inﬂammatory, immunologic, traumatic, neurological and
cardiac diseases [4–6].
The researches also found that the hemorrhagic shock could
induce the ratio imbalance of histone acetyltransferase/histone
deacetylase and thus affect the acetylation of histone or non-
histone. HDACIs could correct such imbalance to improve the
function of tissues and organs, namely protecting the tissues and
organs [7,8]. Gonzales ER et al. adopted VPA and 2-methyl-2-
pentenoic acid (2M2P) in the rat model of hemorrhagic shock.
Compared with the control group after 12 h, 70% of rats in VPA
treatment group and 12% of rats in 2M2P treatment group sur-
vived, while no rat survived in the control group [9]. TomLin et al.
compared the effect of three HDACIs (VPA, trichostatin A and
SAHA) in the treatment of SD rats with hemorrhagic shock. The
lung cells of rats in the control group had no histone acetylation,
while rats in the resuscitation group showed the state of over-
acetylation. These results indicated that the mechanism of HDA-
CIs on the protection of rat model of hemorrhagic shock was
extremely complicated [10]. With the increase in the risk factors of
trafﬁc accidents and natural disasters, the incidence of
hemorrhagic shock is also increased. Accordingly, the study on
the mechanism of HDACIs in the hemorrhagic shock will be of
critical signiﬁcance.
In this study, the method of arterial and venous cannulation
with the time-divided bleeding was employed to build the model
of severe hemorrhagic shock. The modeled rats were randomly
divided into four groups, namely the shock group,
shock + SAHA group, shock + autogenous transfusion group
and shock + SAHA + autogenous transfusion group. The spleen
of rats was separated and the apoptosis of spleen cells was
detected in each group. The statistical analysis was performed.
Afterwards, real-time PCR and western blot were employed to
detect the expression of BCL-2, BAX and caspass3 in the spleen
of rats in each group, in order to specify the mechanism of
HDACIs in the hemorrhagic shock and the synergistic effect of
emergency usage and transfusion.2. Materials and methods
2.1. Materials
2.1.1. Laboratory animals
A total of 60 speciﬁc pathogen free (SPF) male SD rats, with
the weight of (350 ± 50) g, were purchased from Department of
Laboratory Animal Science, Nanchang University. They were
given the standard pellet diet in the standard animal cage, with 5
rats in each cage. Rats were given the diet and drinking freely
during the experiment, with the good ventilation in the feeding
room and natural lighting day and night. The room temperature
was maintained at (18–25) C. The design scheme, operation
procedure and animal ethics of this study had been reviewed and
approved by Medical College of Nanchang University.2.1.2. Reagents and instruments
The lactate assay kit was purchased from Nanjing Jiancheng
Bioengineering Institute; SAHA from Selleck (America); Tunel
assay kit from Vazyma (America); RNA extraction kit from
Ambion (America); reverse transcription kit from Promega
(America); GoTaq® qPCR Master Mix from Promega (Amer-
ica); ReadyPrep protein extraction kit from Bio-Rad (America);BCA protein assay kit from Vazyme Biotech (China); BCL-2,
BAX, caspass3 monoclonal antibody and horseradish peroxi-
dase (HRP) labeled secondary antibodies from Beijing Zhong-
shan Jinqiao Biotechnology; PVDF membrane (0.22 mm) from
Millipore (America); ECL chemiluminescence assay kit from
Millipore (America).
The micro-injection pump was purchased from B. Braun
Melsungen (Germany); the biological and functional experi-
mental system from Chengdu Techman Software Co., Ltd.; the
quantitative DNA analyzer was Qubit Fluorometer; UV2450 UV
spectrophotometer from Shimadzu (Japan); the ﬂuorescence
quantitative PCR was Applied Biosystems 7500.2.2. Methods
2.2.1. Modeling and grouping [11]
The method of arterial and venous cannulation with the time-
divided bleeding was employed to build the model of severe
hemorrhagic shock. SPF SD rats had 7 d of adaptive feeding,
with the fasting 6 h before the experiment. Rats were given the
intraperitoneal injection of 2% pentobarbital under the sterile
condition for the anesthesia (30 mg/kg). The skin on the right
groin and back was prepared for the disinfection. An oblique
incision was made in the lower abdomen and then the micro-
scopy technique was performed to separate the artery and vein.
PE50 catheter was placed and ﬁxed in the femoral artery and
vein. The method of arterial and venous cannulation with the
time-divided bleeding was employed to build the rat model of
severe shock that the total amount of blood loss occupied 60%
of the total blood volume. 50000 IU penicillin was injected to
prevent from the infection. The mean arterial pressure was
maintained at (45 ± 5) mmHg. The measurement of blood lactic
acid was employed to verify the model.
After the veriﬁcation, the modeled rats were randomly
divided into four groups, namely the shock group,
shock + SAHA group, shock + autogenous transfusion (5 mL,
heparin anticoagulation, and half an hour of transfusion) and
shock + SAHA + autogenous transfusion. SAHA was diluted
into 1 mL (0.1% DMSO as the solvent) according to the dose of
8 mg/kg and it was pumped in the vein for 10 min through the
micro-injection pump. After 3 h, the spleen tissue of rats was
separated and TUNEL test was performed. The remained tissues
were stored in the liquid nitrogen quickly.2.2.2. TUNEL to detect the cell apoptosis
The spleen tissue was ﬁxed with 4% formaldehyde. The
tissue sections were placed in the staining jar to be washed with
dimethylbenzene twice, with 5 min each time. Afterwards, they
were washed with anhydrous ethanol twice, with 3 min each
time. Then they were washed with 95% and 75% ethanol
respectively, with 3 min each time. After being reacted in 20 mg/
mL DNase-free proteinase K at (20–37) C for 15 min, they
were washed with PBS for 3 times. The preparation of TUNEL
solution and the staining were performed according to the in-
struction manual of assay kit. The counting was done under the
high power ﬁeld and the ﬂuorescence analysis software was
employed to analyze the experimental data. Image-Pro Plus 6.0
was used to count the positive cells. The speciﬁc steps were:
open 200× ﬁeld photo-measure-count/size-image-ﬂatten back-
ground-20 px, balance the background of photo by 20 px and
then count automatically.
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The spleen tissue was taken out from the liquid nitrogen and
then the total RNA was extracted (according to the instruction
manual of RNA extraction kit). Qubit Fluorometer was employed
to detect the concentration and purity of RNA. The total RNA
was transcripted reversely into cDNA according to the instruction
manual of reverse transcription kit. Real-time PCRwas employed
to detect the related genes. The mRNA sequence of Bcl-2 gene
could be referred to NCBI database and then the real-time PCR
primers could be designed. All primers were synthesized by
Shanghai Sangon Biotech, with the speciﬁc sequence shown as
follows: Bcl-2 (NM_000633.2). For: GGTGAACTGGGG-
GAGGATTG; Rev: GCATGCTGGGGCCATATAGT; BAX
(NM_017059); For: GGATGGCCTCCTTTCCTACTTC; Rev:
ACCTGAGGTTTATTGGCACCT; CASP3 (NM_012922); For:
AAGTGACCATGGACAACAACG; Rev: GCCTCCACTGG-
TATCTTCTGG; ACTB (NM_031144); For: ACCCGCGAG-
TACAACCTTCTT; Rev: TCATCTTTTCACGGTTGGCCT.
Bymeasuring the Ct value of each gene ampliﬁcation, Ct value
was negatively related to the starting copy number of DNA. The
double DCt method was adopted to calculate the relative
expression of target gene: the mean of three parallel repeated
experiments was treated as the CT value of each sample,
DCT = CT (target gene) − CT (reference), DDCT = DCT
(sample) − DCT (control). Therefore, the relative expression of
target gene = 2 − DDCT and the relative expression of control
group was 20 = 1 [12]. The reverse transcription system was
(20 mL): 5 × GoTaq® qPCR Master Mix 4 mL; 1 mL reverse
transcriptase; 1 mg RNA template (1 mg RNA). The reaction
conditions included: Initial denaturation at 95 C for 10 min;
denaturation at 95 C for 10 s; the annealing temperature was
set according to Tm value of primers for 20 s, with the
extension at 72 C for 33 s and 40 cycles.Table 1
Relative expression of real-time PCR.
Control Shock + SAHA Blood trans Blood
trans + SAHA
Bcl-2 1 1.83 ± 0.52* 1.62 ± 0.38* 2.11 ± 2.16**
BAX 1 0.26 ± 0.96* 0.63 ± 0.58** 0.71 ± 0.36*
caspass3 1 0.74 ± 0.48* 0.81 ± 0.55* 0.75 ± 0.41*
*vs Control, P < 0.05; **vs Shock + Blood trans, P < 0.05.2.2.4. Western blot
The spleen tissue was ground to be powder in the liquid
nitrogen. ReadyPrep protein extraction kit was used to extract
the histone. After being put on the ice, the probe-type ultrasound
was used to produce the short impact with the appropriate fre-
quency on the ice. The lysis mixture was centrifuged at 4 C and
13000 r/min for 20 min. The supernatant was transferred to the
new centrifuge tube. BCA kit was employed to detect the protein
concentration.
SDS-PAGE electrophoresis was performed on the protein
samples. The gel was soaked in the transfer buffer for 10 min of
equilibrium. It was installed with the transfer ‘sandwich’, 100 V
and (45–60) min. After the transfer, PVDF membrane was
washed with TBS for (10–15) min. The primary antibody with
the appropriate degree of dilution was added (diluted with TBST
containing 1% (w/v) skimmed milk powder). It was incubated at
the room temperature for 2 h and then the membrane was
washed with TBST for 3 times, with (5–10) min each time. The
membrane was incubated with the secondary antibody (1:10000,
HRP-labeled) that was diluted with TBST containing 0.05% (w/
v) skimmed milk powder. It was washed with TBST for 3 times,
with (5–10) min each time. It was exposed and then photo-
graphed to save the experimental results. Quantity one v4.62
was used to measure the gray value of molecular band (trace
tracking). The semi-quantitative value of target protein/reference
protein was treated as the quantitative foundation. The statistical
analysis was performed as well.2.2.5. Statistical analysis
The experimental data was treated with SPSS17.0. The re-
sults were expressed by x ± SD. The t test was employed for the
comparison between groups and the analysis of variance for the
comparison among groups. Difference is considered signiﬁcant
at P < 0.05.
3. Results
3.1. Modeling of rat with severe hemorrhagic shock
The blood loss volume of rat (mL) = 0.06 × weight
(g) + 0.77. During the modeling, 5 rats died because of the
excessive loss of blood. The mean arterial blood pressure and
blood lactic acid were monitored to verify the model. The results
indicated that the mean weight of rats after the modeling was
(325.6 ± 17.6) g, which had no signiﬁcant difference from that
of (328.6 ± 20.6) before the modeling (P > 0.05). Arterial
pressure (mmHg) of rats after the modeling was (48.2 ± 3.3),
which was signiﬁcantly decreased than that of (112.68 ± 2.85)
mmHg before the modeling (P < 0.01). The content of blood
lactic acid was (7.38 ± 0.67) mM before the modeling; while it
was (13.44 ± 1.04) mM after the modeling, which was increased
by 82% than that in the control group (P < 0.05). Therefore, 55
rats had the successful modeling of severe hemorrhagic shock,
with the success rate of 92%.
3.2. Comparison of spleen cell apoptosis of rats between
groups
The spleen tissue of each group was stained according to the
instruction manual of assay kit. Then the ﬂuorescence detection
was performed and Image-Pro Plus 6.0 was employed to count
the positive cells. According to the results of statistics, the
number of positive cells in the control (shock) group,
shock + SAHA group, shock + BLOOD transfusion group and
shock + SAHA + BLOOD transfusion group was 70.75, 43.83,
40.17 and 24.25, respectively. It could be indicated that the cell
apoptosis was most serious in the hemorrhagic model. After the
intervention of HDACIs and the autogenous transfusion, the
tissue injury was a bit recovered. Where, the cell apoptosis was
least in the shock + SAHA + autogenous transfusion group
(P < 0.05).
3.3. Study on difference in expression of apoptosis-
related genes in spleen tissue of rats in each group
Real-time PCR and western blot were employed to detect the
expression of BCL-2, BAX and caspass3 in the spleen of rats at
mRNA and protein levels in each group, with results shown in
Table 1. Taking the expression in the control group as 1,
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HDACIs and the autogenous transfusion, the relative expression
of BCL-2 was signiﬁcantly increased (P < 0.05), where the
relative expression of BCL-2 was highest in the
shock + SAHA + autogenous transfusion group (P < 0.05).
According to the further analysis on the change in the expression
of BAX gene, it could be indicated that after the intervention of
HDACIs and the autogenous transfusion, the relative expression
of BAX was signiﬁcantly decreased (P < 0.05), where the rela-
tive expression of BAX was increased in the shock + autogenous
transfusion and shock + SAHA + autogenous transfusion group
was increased compared with that in the intervention group of
single HDACIs (P < 0.05). The change in the expression of
caspass3 was similar to BAX, namely the relative expression of
caspass3 was signiﬁcantly decreased after the intervention of
HDACIs and the autogenous transfusion (P < 0.05) (see
Table 2).Table 2
Results of western blot (gene/b-actin).
Control Shock +
SAHA
Shock +
Blood trans
Shock + Blood
trans + SAHA
Bcl-2 0.83 ± 0.21 1.33 ± 0.50* 1.22 ± 0.68* 2.21 ± 1.67**
BAX 1.33 ± 0.52 0.66 ± 0.56* 0.68 ± 0.48* 0.69 ± 0.46*
caspass3 1.19 ± 0.47 0.75 ± 0.29* 0.76 ± 0.55* 0.55 ± 0.51*
*vs Control, P < 0.05; **vs Shock + Blood trans, P < 0.05.According to the results of analysis at the protein level, the
intervention of HDACIs and the autogenous transfusion could
all increase the expression of BCL-2, where the relative
expression of BCL-2 gene was highest in the
SAHA + autogenous transfusion group (P < 0.05). After the
intervention of HDACIs and the autogenous transfusion, the
relative expression of BAX was signiﬁcantly decreased
(P < 0.05), but there was no signiﬁcant difference between
shock + SAHA group, shock + autogenous transfusion group
and shock + SAHA + autogenous transfusion group. The change
in the expression of caspass3 was similar to BAX, namely the
relative expression of caspass3 was signiﬁcantly decreased after
the intervention of HDACIs and the autogenous transfusion
(P < 0.05). As a whole, the change in the expression of BCL-2,
BAX and caspass3 was similar at mRNA and protein levels.
4. Discussion
The hemorrhagic shock could induce the ratio imbalance of
histone acetyltransferase/histone deacetylase and thus affect the
acetylation of histone or non-histone. HDACIs could correct
such imbalance to improve the function of tissues and organs,
namely protecting the tissues and organs. According to the
previous literature, the treatment of HDACIs could increase the
survival rate of animals with hemorrhagic shock, namely
inhibiting the cell apoptosis and protecting the survival and
function of cells. But the mechanism of apoptosis inhibition was
different. In the process of studying the molecular mechanism of
HDACIs, VPA could promote the histone acetylation and thus
increase the survival rate of rats with life-threatening bleeding
[13,14]. VPA could increase the expression of BCL-2 gene and
protein through b-catenin pathway to protect the neurons.
Nikolaos Zacharias et al. proposed that such mechanism wasrelated to phosphoinositol3-kinase and the reverse serine thre-
onine kinase (AKT); then Bcl-2 was used as the anti-apoptosis
factor to increase the survival rate of animals with hemorrhag-
ic shock [15–17]. Accordingly, HDACIs could activate the AKT
pathway to induce the apoptosis inhibition; meanwhile
HDACIs could increase the protein acetylation, reduce BAD
of cells, increase the expression of Bcl-2 and inhibit the cell
apoptosis, which would greatly improve the survival and
function of renal cells of rats with hemorrhagic shock [18–20].
The inhibition against the cell apoptosis is the important
biological effect of HDACIs. But its molecular mechanism on
the cells is not only to inhibit the cell apoptosis, but also stress,
regulate, promote or inhibit the transcription and expression of
cytokines. According to the published literature, there had been
no treatment protocol of transfusion resuscitation in HDACIs
treatment of animals with hemorrhagic shock. But in this study,
it's regarded that the transfusion resuscitation was the most
important method to correct the hemorrhagic shock and its
resuscitation effect was irreplaceable.
To study the protection mechanism of HDACIs and specify
the correlation between HDACIs and transfusion, in this study,
the time-divided bleeding method was employed to build the rat
model of hemorrhagic shock and the modeled animals were
divided into four groups, namely the shock group, shock + SAHA
group, shock + autogenous transfusion group and
shock + SAHA + autogenous transfusion group. At ﬁrst, it was to
study the relationship between the protection and apoptosis of
spleen cells of rats with hemorrhagic shock after the treatment of
autogenous transfusion and SAHA. According to the results, it
could be indicated that the cell apoptosis was most serious in the
hemorrhagic model group (namely the control group). After the
intervention of HDACIs and the autogenous transfusion, the
tissue injury was a bit recovered. Where, the cell apoptosis was
least in the shock + SAHA + autogenous transfusion group
(P < 0.05). It showed that SAHA and autogenous transfusion
could all protect the injured tissues, which was in accordance
with the previous ﬁndings. Gonzales ER et al. used VPA and
2M2P to treat the rats with hemorrhagic shock. After 12 h,
compared with the control group, 70% of rats in VPA group and
12% of rats in 2M2P group were survived, but no rat survived in
the control group. It indicated that the acetylation of histones
H2A, H3, and H4 was related to the survival. The cytotoxicity
factors showed that VPA could signiﬁcantly improve the hepa-
tocellular function of rats with hemorrhagic shock [9,21,22]. In this
study, it's regarded that the signiﬁcance of SAHA in the treatment
of hemorrhagic shock was the survival of animals with shock and
the protection of organs (liver, spleen, lung, kidney, heart and
brain); while the anti-apoptosis was one of important mecha-
nisms. Though many researches had reported such perspective,
the previous literature did not discuss its protection of organs with
the autogenous transfusion. In this study, it could be observed
that the single autogenous transfusion or SAHA intervention
treatment could lead to the serious apoptosis, but the apoptosis of
spleen tissues was improved in SAHA + transfusion group,
which could provide the signiﬁcant theoretical foundation for the
clinical treatment of hemorrhagic shock.
Tom Lin et al. compared the effect of VPA, trichostatin A
and SAHA as the resuscitation drugs in the treatment of SD rats
with hemorrhagic shock. The cDNA biological chip detected
that 57 genes had the abnormal expression, where the expression
of 44 genes was increased and the expression of 13 genes was
decreased. These genes with the abnormal expression involved
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tion, transformation and signaling of cells, which indicated that
the protection mechanism of HDACI on rats with hemorrhagic
shock was extremely complicated [10,23,24]. The increased
expression of apoptosis inhibition protein BCL-2 in the acety-
lation could reduce the apoptosis, while the acetylation could
reduce the expression of pro-apoptosis protein BAX and caspass
3, but the autogenous transfusion had the positive effect on the
expression of BAX and caspass 3 [25–27]. According to the
results of this study at mRNA and protein levels, after the
intervention of HDACIs and the autogenous transfusion, the
relative expression of BCL-2 was signiﬁcantly increased
(P < 0.05), where the relative expression of BCL-2 was highest
in the shock + SAHA + autogenous transfusion group
(P < 0.05). After the intervention of HDACIs and the autoge-
nous transfusion, the relative expression of BAX was signiﬁ-
cantly decreased (P < 0.05), where the relative expression of
BAX was lowest in the intervention group of single HDACIs.
The change in the expression of caspass3 was similar to BAX,
namely the relative expression of caspass3 was signiﬁcantly
decreased after the intervention of HDACIs and the autogenous
transfusion (P < 0.05). It indicated that the tissues with ischemia
reperfusion during the transfusion might be the potential factor
to cause the cell apoptosis. As the spleen tissue is of critical
signiﬁcance for the recovery of immunologic function, the
protection of spleen function will be necessary for the prevention
and treatment of hemorrhagic shock. In conclusion, it can be
regarded that SAHA can protect the spleen tissue of rats with
severe hemorrhagic shock, which mainly induce the increased
expression of BCL-2 and the decreased expression of pro-
apoptosis protein BAX and caspass 3. The SAHA with autog-
enous transfusion can jointly protect the spleen tissue.
Conﬂict of interest statement
We declare that we have no conﬂict of interest.
References
[1] Mai A, Rotili D, Tarantino D, Nebbioso A, Castellano S,
Sbardella G, et al. Identiﬁcation of 4-hydroxyquinolines inhibitors
of p300/CBP histone acetyltransferases. Bioorg Med Chem Lett
2009; 19(4): 1132-1135.
[2] Zhang H, Dai X, Qi Y, He Y, Du W, Pang JJ. Histone deacetylases
inhibitors in the treatment of retinal degenerative diseases: over-
view and perspectives. J Ophthalmol 2015; 2015: 250812.
[3] Hidehiko K, Tatsuo N. GCN5 and BCR signaling collaborate to
induce pre-mature B cell apoptosis through depletion of ICAD and
IAP2 and activation of caspase activities. Gene 2008; 419(1–2):
48-55.
[4] Zhang B, West EJ, Van KC, Gurkoff GG, Zhou J, Zhang XM, et al.
HDAC inhibitor increases histone H3 acetylation and reduces
microglia inﬂammatory response following traumatic brain injury
in rats. Brain Res 2008; 1226: 181-197.
[5] Degano AL, Park MJ, Penati J, Li Q, Ronnett GV. MeCP2 is
required for activity-dependent reﬁnement of olfactory circuits.
Mol Cell Neurosci 2014; 59: 63-75.
[6] Colussi C, Illi B, Rosati J, Spallotta F, Farsetti A, Grasselli A, et al.
Histone deacetylase inhibitors: keeping momentum for neuro-
muscular and cardiovascular diseases treatment. Pharmacol Res
2010; 62: 3-10.
[7] Sailhamer EA, Li Y, Smith EJ, Shuja F, Shults C, Liu B, et al.
Acetylation: a novel method for modulation of the immune
response following trauma/hemorrhage and inﬂammatory second
hit in animals and humans. Surgery 2008; 144(2): 204-216.[8] Shults C, Sailhamer EA, Li Y, Liu B, Tabbara M, Butt MU, et al.
Surviving blood loss without ﬂuid resuscitation. J Trauma 2008;
64(3): 629-638.
[9] Gonzales ER, Chen H, Munuve RM, Mehrani T, Nadel A,
Koustova E. Hepatoprotection and lethality rescue by the histone
deacetylase inhibitor valproic acid. J Trauma 2008; 65(3): 554-565.
[10] Halaweish I, Nikolian V, Georgoff P, Li Y, Alam HB. Creating a
‘prosurvival phenotype’ through histone deacetylase inhibition:
past, present, and future. Shock 2015; 44(Suppl. 1): 6-16.
[11] Deng GR, Wu BH, Gao X, Dong YY, Miao X, Huang W, et al.
Effect of histone deacetylase inhibitor on the survival of rats with
severe hemorrhagic shock. Shandong Med J 2015; 55(29): 26-28.
[12] Mortarino M, Franceschi A, Mancianti F, Bazzocchi C, Genchi C,
Bandi C. Quantitative PCR in the diagnosis of Leishmania. Par-
assitologia 2004; 46(1–2): 163-167.
[13] Lin T, Chen H, Koustova E, Sailhamer EA, Li Y, Shults C, et al.
Histone deacetylaseas therapeutic targetin a rodent model of
hemorrhagic shock: effect of different resuscitation strategies on
lung and liver. Surgery 2007; 141(6): 784-794.
[14] Cheng X, Liu Z, Liu B, Zhao T, Li Y, Alam HB. Selective histone
deacetylase 6 inhibition prolongs survival in a lethal two-hit model.
J Surg Res 2015; 197(1): 39-44.
[15] Zacharias N, Sailhamer EA, Li Y, Liu B, Butt MU, Shuja F, et al.
Histone deacetylase inhibitors prevent apoptosis following lethal
hemorrhagic shock in rodent kidney cells. Resuscitation 2010;
82(1): 105-109.
[16] Reddy MA, Natarajan R. Recent developments in epigenetics of
acute and chronic kidney diseases. Kidney Int 2015; 88(2): 250-
261.
[17] Speir RW, Stallings JD, Andrews JM, Gelnett MS, Brand TC,
Salgar SK. Effects of valproic acid and dexamethasone adminis-
tration on early bio-markers and gene expression proﬁle in acute
kidney ischemia-reperfusion injury in the rat. PLoS One 2015;
10(5): e0126622.
[18] Matthews GM, Mehdipour P, Cluse LA, Falkenberg KJ, Wang E,
Roth M, et al. Functional-genetic dissection of HDAC de-
pendencies in mouse lymphoid and myeloid malignancies. Blood
2015; 126(21): 2392-2403.
[19] McDermott J, Jimeno A. Belinostat for the treatment of peripheral
T-cell lymphomas. Drugs Today (Barc) 2014; 50(5): 337-345.
[20] Foss F, Advani R, Duvic M, Hymes KB, Intragumtornchai T,
Lekhakula A, et al. A Phase II trial of Belinostat (PXD101) in
patients with relapsed or refractory peripheral or cutaneous T-cell
lymphoma. Br J Haematol 2015; 168(6): 811-819.
[21] Guo W, Tsujimura K, Otsuka IM, Irie K, Igarashi K, Nakashima K,
et al. VPA alleviates neurological deﬁcits and restores gene
expression in a mouse model of Rett syndrome. PLoS One 2014;
9(6): e100215.
[22] Zhang X, Zhang X, Huang T, Geng J, Liu M, Zheng J. Combi-
nation of metformin and valproic acid synergistically induces cell
cycle arrest and apoptosis in clear cell renal cell carcinoma. Int J
Clin Exp Pathol 2015; 8(3): 2823-2828.
[23] Imesch P, Dedes KJ, Furlato M, Fink D, Fedier A. MLH1 protects
from resistance acquisition by the histone deacetylase inhibitor
trichostatin A in colon tumor cells. Int J Oncol 2009; 35(3): 631-
640.
[24] Samuni Y, Flores-Santana W, Krishna MC, Mitchell JB, Wink DA.
The inhibitors of histone deacetylase suberoylanilide hydroxamate
and trichostatin: a release nitric oxide upon oxidation. Free Radic
Biol Med 2009; 47(4): 419-423.
[25] Pang WJ, Xiong Y, Wang Y, Tong Q, Yang GS. Sirt1 attenuates
camptothecin-induced apoptosis through caspase-3 pathway in
porcine preadipocytes. Exp Cell Res 2013; 319(5): 670-683.
[26] Wu J, Zhu Y, Xu C, Xu H, Zhou X, Yang J, et al. Adenovirus-
mediated p53 and ING4 gene co-transfer elicits synergistic anti-
tumor effects through enhancement of p53 acetylation in breast
cancer. Oncol Rep 2016; 35(1): 243-252.
[27] Duan WX, He MD, Mao L, Qian FH, Li YM, Pi HF, et al. NiO
nanoparticles induce apoptosis through repressing SIRT1 in human
bronchial epithelial cells. Toxicol Appl Pharmacol 2015; 286(2):
80-91.
